黎蘇保注射劑

Land: Taiwan

Taal: Chinees

Bron: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Werkstoffen:

EACH SOLVENT CONTAINS;;SODIUM MERTHIOLATE;;LYSOZYME CHLORIDE;;GUAIACOL GLYCERYL ETHER (EQ TO GUAIFENESIN);;SODIUM CAMPHORSULFONATE (SODIUM CAMSYLATE);;CHYMOTRYPSIN ALPHA-

Beschikbaar vanaf:

力大藥品有限公司 台北巿重慶南路一段１０號　臺企大樓１００３室

farmaceutische vorm:

凍晶注射劑

Samenstelling:

SODIUM CAMPHORSULFONATE (SODIUM CAMSYLATE) (2820002810) 100MG; CHYMOTRYPSIN ALPHA- (4400000601) 5MG; LYSOZYME CHLORIDE (4400001310) 50MG; GUAIACOL GLYCERYL ETHER (EQ TO GUAIFENESIN) (4800001420) 100MG; SODIUM MERTHIOLATE (8404000900) 0.005%; EACH SOLVENT CONTAINS (9800001300) 2ML

Eenheden in pakket:

安瓿附溶液

klasse:

製　劑

Prescription-type:

限由醫師使用

Geproduceerd door:

ESSETI S. A. S. CHEMOPHARMACO-BIOLOGICAL LABORATORY VIA CAVALLIDI BRONZO NO 41 SAN GIORGIO A CREMANO (VAPOLI) IT

therapeutische indicaties:

手術及外傷腫脹之緩解

Product samenvatting:

註銷日期: 1990/10/02; 註銷理由: 未展延而逾期者; 有效日期: 1986/02/01; 英文品名: LISOPULM INJECTION

Autorisatie-status:

已註銷

Autorisatie datum:

1977-02-01